Mohan Jitendra's Form 4 filing
Astera Labs, Inc. (ALAB) · filed Nov 25, 2024
- Accession no.
- 0001736297-24-000055
- Filed
- Nov 25, 2024
- Trade date
- Nov 21, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $17.7M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mohan JitendraCIK 0001998053 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | Common Stock | SSaleDisposed | −28,511 | $103.53F2 | −$2,951,743.83 | 4,471,498 | Indirect | |
| Nov 21, 2024 | Common Stock | SSaleDisposed | −28,511 | $103.53F2 | −$2,951,743.83 | 878,894 | Indirect | |
| Nov 21, 2024 | Common Stock | SSaleDisposed | −28,511 | $103.53F2 | −$2,951,743.83 | 878,895 | Indirect | |
| Nov 21, 2024 | Common Stock | SSaleDisposed | −28,511 | $103.53F2 | −$2,951,743.83 | 628,895 | Indirect | |
| Nov 21, 2024 | Common Stock | SSaleDisposed | −28,511 | $103.53F2 | −$2,951,743.83 | 628,895 | Indirect | |
| Nov 21, 2024 | Common Stock | SSaleDisposed | −28,509 | $103.53F2 | −$2,951,536.77 | 878,892 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 16,298 shares sold at prices ranging from $101.6650 to $102.5900, 91,566 shares sold at prices ranging from $102.7300 to $103.7263, 62,428 shares sold at prices ranging from $103.7300 to $104.6600, and 772 shares sold at prices ranging from $104.7700 to $104.7800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Referenced by the price of 6 transactions in Table I.